New pain block technique tested for heart surgery recovery
NCT ID NCT05320718
First seen Jun 26, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This study compared two ways to control pain after minimally invasive heart bypass surgery: a newer erector spinae plane block (ESPB) versus the standard paravertebral block (PVB). 140 patients received one of the two blocks using the numbing drug ropivacaine. The goal was to see if ESPB works as well as PVB for pain relief, especially when coughing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ropivacaine
- What this could lead to
- If successful, this could show that a newer, simpler nerve block (ESPB) is just as good as the standard one (PVB) for controlling pain after heart surgery.
- What could go wrong
- This is a small, completed study comparing two established techniques. The results may not apply to all heart surgeries or patients, and both blocks carry risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA, LOCAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Anesthesiology,Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
-
Peking University Third Hosptial
Beijing, 100191, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- When pain strikes during C-Section: what Women's stories reveal
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?